96013 Integrated Therapeutics 3
6cp; 2hpw (supporting online activities e.g. Q&A, online module), 2 x 2hpw (workshop)Requisite(s): 96010 Integrated Therapeutics 2 AND 96009 Professional Services 3 AND 96024 Clinical Practice 2
These requisites may not apply to students in certain courses.
There are course requisites for this subject. See access conditions.
Description
Building on Integrated Therapeutics 1 and 2, this subject focuses on the optimal use of pharmacotherapy in the management of renal, gynaecological, obstetric and malignant disorders. The epidemiology, pathophysiology, diagnosis and clinical presentation of illness and disease are reviewed. Using an integrated approach, treatment and management options are considered with reference to relevant pharmacology, medicinal chemistry, formulation, pharmacokinetics and clinical properties of targeted therapies. The use of pharmacotherapy in special populations (paediatrics, geriatrics, palliative care) is highlighted.
Typical availability
Spring session, City campus
Detailed subject description.